HomePZU stock forecast: Pekao reorganisation, dividend guidance

PZU stock forecast: Pekao reorganisation, dividend guidance

Powszechny Zaklad Ubezpieczen (PZU) is Poland’s largest insurer, with the market focused on its planned Bank Pekao reorganisation and 2025 dividend guidance. Past performance is not a reliable indicator of future results. Explore third-party PZU price targets and technical analysis.
By Dan Mitchell
PZU logo displayed on a sign mounted on a building exterior
Photo: Shutterstock

Powszechny Zaklad Ubezpieczen SA (PZU) is trading at 65.28 PLN as of 1:50pm UTC on 2 April 2026, within an intraday range of 64.34–65.70 PLN. Past performance is not a reliable indicator of future results.

Sentiment around the stock reflects several concurrent developments. PZU reported a 12% year-on-year fall in Q4 2025 net profit to 1.47bn PLN, broadly in line with analyst expectations, as intensifying competition in the motor insurance segment and weaker financial income weighed on results, while full-year 2025 net profit rose 25.4% to 6.7bn PLN (Reuters, 26 February 2026). On 25 March 2026, CEO Bogdan Benczak told a parliamentary committee that the dividend from 2025 profits is expected to be at least in line with the prior year's level of 4.47 PLN per share (Biznes PAP, 26 March 2026), reinforcing the group's capital distribution commitment. Additionally, the pending merger and reorganisation with Bank Pekao, under a memorandum of understanding signed in June 2025, remains a structural focus, with finalisation now targeted for the end of 2026 amid ongoing legislative and regulatory processes (Bankier.pl, 26 February 2026). The broader Warsaw market has also faced headwinds, with the WIG index falling to 123,719 points on 2 April 2026, down 0.68% on the session (Trading Economics, 2 April 2026).

Powszechny Zaklad Ubezpieczen stock forecast 2026–2030: Third-party price targets

As of 2 April 2026, third-party Powszechny Zaklad Ubezpieczen stock predictions sit above the current trading level of 65.28 PLN.

Fintel (consensus snapshot)

Fintel records an average 12-month price target of 67.31 PLN for PZU, with a low estimate of 57.57 PLN and a high of 79.59 PLN. The spread of 22.02 PLN between the floor and ceiling targets reflects diverging analyst views on the pace of the planned bancassurance reorganisation with Bank Pekao and the trajectory of motor insurance margins amid intensifying market competition (Fintel, 31 March 2026).

Yahoo Finance (multi-analyst aggregate)

Yahoo Finance aggregates targets from the covering analyst panel and reports an average 12-month price target of 70.79 PLN, with a low estimate of 62.70 PLN and a high of 76 PLN. The range sits 8.5%–16.4% above the current trading level, with analysts citing PZU's record full-year 2025 net profit of 6.7bn PLN and the group's stated intention to maintain at least the prior year's dividend of 4.47 PLN per share as key underpinning factors (Yahoo Finance, 2 April 2026).

MarketScreener (broker consensus)

MarketScreener compiles views from 10 analysts and carries a mean consensus rating of Buy, an average price target of 68.39 PLN, a high estimate of 75.80 PLN, and a low of 62.70 PLN. The consensus Buy rating reflects confidence in PZU's earnings base and capital distribution capacity, while the low estimate of 62.70 PLN anchors the cautious end of the range amid ongoing uncertainty over the legislative timeline governing the Pekao merger (MarketScreener, 2 April 2026).

Investing.com (analyst consensus)

Investing.com reports a 12-month average PZU stock forecast of 70.80 PLN from 10 contributing analysts, with the high estimate at 76 PLN. The constructive skew in the panel reflects expectations that PZU's bancassurance restructuring, once concluded, would improve cross-selling capacity and cost efficiency across the combined group (Investing.com, 2 April 2026).

TradingView (analyst price target tracker)

TradingView aggregates targets from 10 analysts and sets the average 12-month price target at 71.18 PLN, with a maximum estimate of 76 PLN and a minimum estimate of 62.70 PLN. The average sits approximately 9.1% above the current 65.28 PLN level, with the broader analyst community noting PZU's S&P Global A- financial strength rating, affirmed on 11 March 2026 with a positive outlook, as a supportive credit signal (TradingView, 2 April 2026).

Predictions and third-party forecasts are inherently uncertain, as they cannot fully account for unexpected market developments. Past performance is not a reliable indicator of future results.

PZU stock price: Technical overview

The PZU stock price trades at 65.28 PLN as of 1:50pm UTC on 2 April 2026, sitting just above the 30-day simple moving average (SMA) at 65.03 PLN and broadly in line with the 100-day SMA at 66.05 PLN. The short-term moving average picture is mixed: the 20/50/100/200-day SMAs stand at approximately 63.74 / 66.98 / 66.05 / 63.19, with price currently trading between the 30-day and 50-day levels, while the Hull moving average (9) at 65.07 PLN registers a buy signal.

Momentum indicators from TradingView's oscillator suite present a largely neutral reading. The 14-day relative strength index (RSI) sits at 52.46, indicating a mid-range, upper-neutral condition without suggesting the move is overextended in either direction. The average directional index (ADX) at 28.12 indicates an established, though not strongly trending, directional environment.

On the upside, the classic R1 pivot at 67.21 PLN is the nearest reference above the current price; a daily close through that level would bring R2 at 70.35 PLN into view. To the downside, the classic pivot point at 63.99 PLN provides an initial support reference, with the 200-day SMA at 63.19 PLN representing the next meaningful moving-average shelf; losing that level would risk a move towards S1 at 60.85 PLN (TradingView, 2 April 2026).

This is technical analysis for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any instrument.

Powszechny Zaklad Ubezpieczen share price history (2025–2026)

Powszechny Zaklad Ubezpieczen (PZU) is one of Poland's largest financial groups, combining insurance, banking, and asset management under a single roof, and its shares trade on the Warsaw Stock Exchange.

PZU’s stock price opened early September 2025 around 61.05 PLN and drifted lower through the autumn, touching a closing low of 54.60 PLN on 17 October 2025 amid broader market weakness. The stock then reversed sharply, rallying more than 31% from that October trough to close at 71.72 PLN on 4 February 2026, its highest close in the dataset, as investor appetite improved alongside the group's strong full-year earnings momentum.

Since that February peak, PZU has pulled back by roughly 9%, closing 2025 at 67.08 PLN and opening 2026 at 68.78 PLN before softening further into the new year. PZU closed at 65.28 PLN on 2 April 2026, approximately 2.7% below its 2025 year-end close and around 5.1% below its 2026 opening level.

Past performance is not a reliable indicator of future results.

Powszechny Zaklad Ubezpieczen (PZU): Capital.com analyst view

PZU's 2025 performance reflected the group's underlying financial strength, with full-year net profit rising 25.4% year on year to a record 6.7bn PLN and return on equity exceeding 20%, surpassing its own strategic targets. Poland's broader insurance market has remained a structural tailwind, with combined life and non-life premiums projected to exceed 98bn PLN by 2026 and non-life premium growth running at approximately 8% annually. PZU holds dominant market shares of 44% in life insurance and 27% in non-life insurance, which provides a degree of pricing power. However, mid-tier competitors are growing aggressively in motor insurance, where PZU has faced margin pressure, and a structurally declining Polish population presents a longer-term headwind to premium volume growth.

The planned merger with Bank Pekao, targeting completion by the end of 2026, represents a structural pivot that could unlock an estimated 15–20bn PLN in capital surpluses and enhance bancassurance cross-selling. At the same time, it introduces execution risk, with PZU's own CEO acknowledging the possibility of legislative delays as of November 2025. The group's Solvency II ratio of 234% provides a substantial capital buffer, supporting the dividend commitment, though capital market volatility and geopolitical exposure through Baltic and Ukrainian operations remain areas to watch.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Past performance is not a reliable indicator of future results.

Summary – Powszechny Zaklad Ubezpieczen 2026

Past performance is not a reliable indicator of future results.

FAQ

Who owns the most Powszechny Zaklad Ubezpieczen stock?

Powszechny Zaklad Ubezpieczen’s shareholder base can change over time, so the answer depends on the latest official filings. In general, investors should check the company’s most recent shareholder disclosures and Warsaw Stock Exchange announcements for the current position. Ownership concentration can matter because large strategic holders may influence governance, capital allocation, dividend policy and any major corporate actions, including reorganisation plans such as the proposed tie-up with Bank Pekao.

What is the 5 year Powszechny Zaklad Ubezpieczen share price forecast?

There is no single reliable five-year PZU stock forecast. Most published analyst estimates focus on a 12-month horizon, and longer-term projections involve more uncertainty. Over five years, the share price could be influenced by earnings trends, dividend policy, insurance pricing conditions, the Bank Pekao reorganisation, regulation and broader Polish market sentiment. Longer forecasts should therefore be treated as scenarios rather than precise expectations.

Is Powszechny Zaklad Ubezpieczen a good stock to buy?

Whether Powszechny Zaklad Ubezpieczen is a good stock to buy depends on your objectives, time horizon and risk tolerance. The company has reported strong full-year 2025 profit, maintains a significant market position and has indicated continued dividend support. At the same time, investors still need to weigh pressure in motor insurance, regulatory uncertainty and execution risk around the Pekao reorganisation. That balance means the stock may appeal to some market participants, but it may not suit others.

Could Powszechny Zaklad Ubezpieczen stock go up or down?

Yes, Powszechny Zaklad Ubezpieczen stock could move in either direction, depending on how company-specific and market-wide factors develop. Supportive influences may include earnings resilience, dividend expectations, capital strength and progress on strategic restructuring. On the other hand, weaker insurance margins, delays to legislative or regulatory approvals, and broader weakness in Polish equities could weigh on the share price. Technical indicators currently point to a largely neutral backdrop rather than a clear directional trend.

Should I invest in Powszechny Zaklad Ubezpieczen stock?

That is a personal decision rather than a general conclusion. Before investing in Powszechny Zaklad Ubezpieczen stock, it is worth considering your financial goals, experience, tolerance for losses and preferred time frame. Reviewing the company’s earnings profile, dividend outlook, competitive position and restructuring plans may help build context, but none of these remove market risk. If you are unsure, consider doing further research or seeking independent financial advice before making any investment decision.

Can I trade Powszechny Zaklad Ubezpieczen CFDs on Capital.com?

Yes, you can trade Powszechny Zaklad Ubezpieczen CFDs on Capital.com. Trading share CFDs lets you speculate on price movements without owning the underlying asset and to take long or short positions. However, contracts for difference (CFDs) are traded on margin, and leverage amplifies both profits and losses. You should ensure you understand how CFD trading works, assess your risk tolerance, and recognise that losses can occur quickly.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.